Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1982-4-12
|
pubmed:abstractText |
Thyroid hormones are known to enhance normal erythroid colony growth (CFUE) and this enhancement depends on a functional beta 2-adrenergic receptor mechanism. we investigated the response of Friend cells to thyroid hormones, catecholamines, and other compounds influencing cellular cAMP activity. The thyroid hormones L-T3, L-T4, and "reverse T3" stimulated erythroleukemia colony growth in a serum-substituted methylcellulose culture system with peak activity at 10(-7) M. Various beta-adrenergic compounds enhanced Friend leukemia colony growth; however, the alpha-adrenergic agonist phenylephrine was inactive. Dibutyryl cyclic AMP and the phosphodiesterase inhibitor theophylline also enhanced Friend leukemia colony formation. Adrenergic antagonists with beta 2 specificity abrogated the stimulatory effect of L-T3, L-T4, and of "reverse T3" at equimolar concentrations. These experiments demonstrate that thyroid hormones, beta-adrenergic agonists, the phosphodiesterase inhibitor theophylline, and dbcAMP have a direct effect on the proliferation of Friend erythroleukemia cells. We conclude that thyroid hormones' action requires a functioning beta 2-adrenergic receptor mechanism. Thyroid hormones directly modulate the growth of neoplastic erythroid cells in a manner consistent with their effects on normal erythropoiesis.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Butoxamine,
http://linkedlifedata.com/resource/pubmed/chemical/Catecholamines,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, beta,
http://linkedlifedata.com/resource/pubmed/chemical/Thyroid Hormones
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0301-472X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
821-8
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:6276212-Animals,
pubmed-meshheading:6276212-Butoxamine,
pubmed-meshheading:6276212-Catecholamines,
pubmed-meshheading:6276212-Cell Division,
pubmed-meshheading:6276212-Cells, Cultured,
pubmed-meshheading:6276212-Erythropoiesis,
pubmed-meshheading:6276212-Friend murine leukemia virus,
pubmed-meshheading:6276212-Humans,
pubmed-meshheading:6276212-Leukemia, Erythroblastic, Acute,
pubmed-meshheading:6276212-Leukemia, Experimental,
pubmed-meshheading:6276212-Receptors, Adrenergic,
pubmed-meshheading:6276212-Receptors, Adrenergic, beta,
pubmed-meshheading:6276212-Thyroid Hormones
|
pubmed:year |
1981
|
pubmed:articleTitle |
Beta 2 receptor-mediated stimulation of Friend erythroleukemia cell growth by thyroid hormones.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|